{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:12:03Z","timestamp":1792267923619,"version":"4.4.0"},"reference-count":82,"publisher":"FapUNIFESP (SciELO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760170391","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T20:40:49Z","timestamp":1519072849000},"source":"Crossref","is-referenced-by-count":63,"title":["The war on cryptococcosis: A Review of the antifungal arsenal"],"prefix":"10.1590","volume":"113","author":[{"given":"Ahmad","family":"Mourad","sequence":"first","affiliation":[{"name":"Duke University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Perfect","sequence":"additional","affiliation":[{"name":"Duke University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/339680","article-title":"A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy","volume":"185","author":"Aberg JA","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1469-0691.2011.03741.x","article-title":"Immunotherapy of Cryptococcus infections","volume":"18","author":"Antachopoulos C","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S409","DOI":"10.1086\/429337","article-title":"Successful use of amphotericin B lipid complex in the treatment of cryptococcosis","volume":"40","author":"Baddour LM","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley J","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic T","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic T","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic T","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"26","key":"ref8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware DR","year":"2014","journal-title":"N Engl J Med"},{"issue":"9423","key":"ref9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer AE","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"ref10","first-page":"85","article-title":"Itraconazole in the treatment of cryptococcal meningitis","volume":"75","author":"Chotmongkol V","year":"1992","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00002030-199306000-00011","article-title":"Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS","volume":"7","author":"Coker RJ","year":"1993","journal-title":"AIDS"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/eji.1830220617","article-title":"Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans","volume":"22","author":"Collins HL","year":"1992","journal-title":"Eur J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw172.1343","article-title":"A novel therapeutic approach for cryptococcal meningitis","volume":"3","author":"Cutshaw D","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day JN","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"Gans J","year":"1992","journal-title":"AIDS"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome","volume":"91","author":"Denning DW","year":"1991","journal-title":"Am J Med"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002030-198902000-00004","article-title":"The value of cryptococcal serum antigen screening among HIV-positive\/AIDS patients in Kinshasa, Zaire","volume":"3","author":"Desmet P","year":"1989","journal-title":"AIDS"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer F","year":"2008","journal-title":"PLoS ONE"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110285","article-title":"A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi","volume":"9","author":"Gaskell KM","year":"2014","journal-title":"PLoS ONE"},{"key":"ref20","article-title":"Comparative epidemiology and outcomes of HIV, non-HIV non-transplant and organ transplant associated cryptococcosis: a population-based study","author":"George IA","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill JR","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill RJ","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/infdis\/170.1.238","article-title":"High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection","volume":"170","author":"Haubrich RH","year":"1994","journal-title":"J Infect Dis"},{"key":"ref24","series-title":"HRSA - Organ Procurement and Transplantation Network","year":"2017"},{"key":"ref25","author":"Jarvis JN","year":"2017"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis JN","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda T","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref28","series-title":"Advancing cryptococcal meningitis treatment for Africa (ACTA)","author":"Kanyama C","year":"2017"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1097\/QAI.0000000000000484","article-title":"Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature","volume":"68","author":"Kaplan JE","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/cimm.1999.1460","article-title":"Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18","volume":"193","author":"Kawakami K","year":"1999","journal-title":"Cell Immunol"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.4049\/jimmunol.159.11.5528","article-title":"IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production","volume":"159","author":"Kawakami K","year":"1997","journal-title":"J Immunol"},{"issue":"2","key":"ref32","first-page":"123","article-title":"Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans","volume":"13","author":"Kawakami K","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2249.1996.14723.x","article-title":"IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans","volume":"104","author":"Kawakami K","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen RA","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen RA","year":"1990","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen RA","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders AC","year":"1997","journal-title":"AIDS"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality","volume":"2","author":"Letang E","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty CA","year":"2007","journal-title":"Trop Med Int Health"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"62","author":"Longley N","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"16","key":"ref41","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200011100-00029","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy","volume":"14","author":"Martinez E","year":"2000","journal-title":"AIDS"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"Mayanja-Kizza H","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/cid\/ciu937","article-title":"Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012","volume":"60","author":"McKenney J","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/clinids\/22.5.838","article-title":"High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS","volume":"22","author":"Menichetti F","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw261","article-title":"Disseminated cryptococcosis with brain involvement in patients with chronic lymphoid malignancies on ibrutinib","volume":"4","author":"Messina JA","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya DB","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients","volume":"45","author":"Micol R","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13693780701851695","article-title":"Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis","volume":"46","author":"Milefchik E","year":"2008","journal-title":"Med Mycol"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","article-title":"Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study","volume":"38","author":"Mussini C","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0163-4453(90)91727-U","article-title":"The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus","volume":"21","author":"Nelson MR","year":"1990","journal-title":"J Infect"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum JC","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cid\/ciw739","article-title":"Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults","volume":"64","author":"Panackal AA","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref53","article-title":"Dexamethasone in cryptococcal meningitis","volume":"375","author":"Panackal AA","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas PG","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas PG","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect JR","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/cid\/ciw153","article-title":"Editorial commentary: life-saving antimicrobial drugs: what are we doing to pricing and availability?","volume":"62","author":"Perfect JR","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect JR","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum P","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham R","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein J","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/515074","article-title":"Early mycological treatment failure in AIDS-associated cryptococcal meningitis","volume":"28","author":"Robinson PA","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes MA","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00002030-200107270-00019","article-title":"Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy","volume":"15","author":"Rollot F","year":"2001","journal-title":"AIDS"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"Saag MS","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo T","year":"2014","journal-title":"MBio"},{"key":"ref67","series-title":"Efficacy of oral APX001 in a murine model of cryptococcal meningitis","author":"Schell W","year":"2017"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/22.2.315","article-title":"Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS","volume":"22","author":"Sharkey PK","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui AA","year":"2005","journal-title":"J Immunol"},{"issue":"8","key":"ref70","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection","volume":"80","author":"Singh N","year":"2005","journal-title":"Transplantation"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal meningitis: epidemiology and therapeutic options","volume":"6","author":"Sloan DJ","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"5","key":"ref72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/cid\/ciw786","article-title":"Impact of infectious diseases consultation on mortality of cryptococcal infection in patients without HIV","volume":"64","author":"Spec A","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","DOI":"10.2217\/fvl.13.71","article-title":"Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis","volume":"8","author":"Ssekitoleko R","year":"2013","journal-title":"Future Virol"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00126334-200307010-00019","article-title":"Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda","volume":"33","author":"Tassie JM","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/cid\/cix430","article-title":"Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in cryptococcal meningitis","volume":"65","author":"Tenforde MW","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses","volume":"63","author":"Thompson 3rd GR","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref77","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study","volume":"36","author":"Vibhagool A","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson PR","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"ref79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1473-3099(17)30245-1","article-title":"The relentless march of cryptococcal meningitis","volume":"17","author":"Williamson PR","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/23744235.2015.1044260","article-title":"Voriconazole: a novel treatment option for cryptococcal meningitis","volume":"47","author":"Yao Y","year":"2015","journal-title":"Infect Dis"},{"issue":"4","key":"ref81","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/IAI.74.4.2161-2168.2006","article-title":"Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis","volume":"74","author":"Zhou Q","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"ref82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial","volume":"4","author":"Zolopa A","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v113n7\/0074-0276-mioc-113-4-e170391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T22:26:26Z","timestamp":1751408786000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762018000700202&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":82,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0074-02762018000700202"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760170391","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,19]]}}}